Spatiotemporal control in biomedicine: photoswitchable peptides and foldamers
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Eszter Erdei, Juan Toledo Marcos, Nikolett Varró, Kata Horváti, Bernadett Bacsa, István M. Mándity |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors
por: Simon Miguel M. Lopez, et al.
Publicado: (2025)
por: Simon Miguel M. Lopez, et al.
Publicado: (2025)
Nimodipine reduces microglial activation in vitro as evidenced by morphological phenotype, phagocytic activity and high‐throughput RNA sequencing
por: István Pesti, et al.
Publicado: (2025)
por: István Pesti, et al.
Publicado: (2025)
Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
por: Denise Pajonczyk, et al.
Publicado: (2024)
por: Denise Pajonczyk, et al.
Publicado: (2024)
Biodiversity2Drugs—Renaissance of exploring nature‐derived peptides for GPCR ligand discovery
por: Christian W. Gruber, et al.
Publicado: (2025)
por: Christian W. Gruber, et al.
Publicado: (2025)
Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II‐induced cAMP signalling
por: Sanika Mohagaonkar, et al.
Publicado: (2026)
por: Sanika Mohagaonkar, et al.
Publicado: (2026)
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration
por: Samantha Arokiasamy, et al.
Publicado: (2024)
por: Samantha Arokiasamy, et al.
Publicado: (2024)
R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases
por: Bruno Poirier, et al.
Publicado: (2024)
por: Bruno Poirier, et al.
Publicado: (2024)
Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel
por: Chen Pan, et al.
Publicado: (2024)
por: Chen Pan, et al.
Publicado: (2024)
A novel recombinant peptide, RGD‐Latcripin‐7A, targeting neovascularization in skin transplantation: Tissue regeneration and autophagy mechanism
por: Xuzi Zhang, et al.
Publicado: (2026)
por: Xuzi Zhang, et al.
Publicado: (2026)
Intracellular pathways of calcitonin gene‐related peptide‐induced relaxation of human coronary arteries: A key role for Gβγ subunit instead of cAMP
por: Tessa de Vries, et al.
Publicado: (2024)
por: Tessa de Vries, et al.
Publicado: (2024)
A novel peptide‐fentanyl conjugate with μ‐opioid and neuropeptide FF receptor agonism produces antinociception with limited side effects in male mice
por: Ning Li, et al.
Publicado: (2025)
por: Ning Li, et al.
Publicado: (2025)
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice
por: Rongjie Liu, et al.
Publicado: (2025)
por: Rongjie Liu, et al.
Publicado: (2025)
Gβγ subunit activation of K V 7 and BK Ca channels underlies calcitonin gene‐related peptide vasorelaxation in myogenic rat coronary resistance arteries
por: Lucy A. Donovan, et al.
Publicado: (2026)
por: Lucy A. Donovan, et al.
Publicado: (2026)
Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
por: Jin‐Ru Zou, et al.
Publicado: (2026)
por: Jin‐Ru Zou, et al.
Publicado: (2026)
Neuroprotective amyloid β N‐terminal peptides differentially alter human α7‐ and α7β2‐nicotinic acetylcholine (nACh) receptor single‐channel properties
por: Catherine F. Roberts, et al.
Publicado: (2024)
por: Catherine F. Roberts, et al.
Publicado: (2024)
An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects
por: James Goodman, et al.
Publicado: (2025)
por: James Goodman, et al.
Publicado: (2025)
Efficacy and safety of a selective partial agonist for nociception/orphanin‐FQ peptide (NOP) receptors in patients with insomnia disorder
por: Garth T. Whiteside, et al.
Publicado: (2025)
por: Garth T. Whiteside, et al.
Publicado: (2025)
TRPA1 up‐regulation mediates oxidative stress in a pulpitis model in vitro
por: Árpád Kunka, et al.
Publicado: (2024)
por: Árpád Kunka, et al.
Publicado: (2024)
Biased agonists of GPR84 and insights into biological control
por: Vincent B. Luscombe, et al.
Publicado: (2024)
por: Vincent B. Luscombe, et al.
Publicado: (2024)
Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients
por: Pedro R. J. Almeida, et al.
Publicado: (2024)
por: Pedro R. J. Almeida, et al.
Publicado: (2024)
The eyes of the beholder: Perceived barriers to successful drug repurposing
por: Zsuzsanna Ida Petykó, et al.
Publicado: (2025)
por: Zsuzsanna Ida Petykó, et al.
Publicado: (2025)
D‐amino acid oxidase as a chemogenetic tool for spatiotemporally controlled hydrogen peroxide production: The oxygen connection
por: Wiebke Maurer, et al.
Publicado: (2025)
por: Wiebke Maurer, et al.
Publicado: (2025)
The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
por: Jianxing Zhou, et al.
Publicado: (2024)
por: Jianxing Zhou, et al.
Publicado: (2024)
Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
por: Alberto Santiago‐Balmaseda, et al.
Publicado: (2026)
por: Alberto Santiago‐Balmaseda, et al.
Publicado: (2026)
Photochemical control of cold‐sensitive TRPA1 ion channel gating for modulation of pain sensation
por: Junli Peng, et al.
Publicado: (2025)
por: Junli Peng, et al.
Publicado: (2025)
Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary function
por: Rumaitha Al‐Hosni, et al.
Publicado: (2025)
por: Rumaitha Al‐Hosni, et al.
Publicado: (2025)
Clinically relevant niclosamide concentrations modulate TMEM16A and CaV1.2 channels to control artery tone and capillary diameter
por: Rachel Kaye, et al.
Publicado: (2025)
por: Rachel Kaye, et al.
Publicado: (2025)
Feedback control of excitability and high K + induced epileptiform bursts in male rat hippocampal slices with a photocaged adenosine A 1 receptor agonist
por: Erine Craey, et al.
Publicado: (2026)
por: Erine Craey, et al.
Publicado: (2026)
Chemosensory signalling in human sperm is controlled by Ca2+ influx via CatSper and Ca2+ clearance via plasma membrane Ca2+ ATPases
por: Leonie Herrmann, et al.
Publicado: (2025)
por: Leonie Herrmann, et al.
Publicado: (2025)
Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
por: Rolien Bosch, et al.
Publicado: (2024)
por: Rolien Bosch, et al.
Publicado: (2024)
The contribution of NaV1.6 to the efficacy of voltage‐gated sodium channel inhibitors in wild type and NaV1.6 gain‐of‐function (GOF) mouse seizure control
por: James P. Johnson, et al.
Publicado: (2024)
por: James P. Johnson, et al.
Publicado: (2024)
Removing the physician from the equation: Patient‐controlled, home‐based therapeutic drug self‐monitoring of tacrolimus
por: Marinus Hazenbroek, et al.
Publicado: (2024)
por: Marinus Hazenbroek, et al.
Publicado: (2024)
Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis
por: Javier Milara, et al.
Publicado: (2024)
por: Javier Milara, et al.
Publicado: (2024)
Have plastic culture models prevented the discovery of effective cancer therapeutics?
por: Kevin M. Tharp
Publicado: (2024)
por: Kevin M. Tharp
Publicado: (2024)
To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury
por: Jonathan M. de Jesus, et al.
Publicado: (2025)
por: Jonathan M. de Jesus, et al.
Publicado: (2025)
Recent innovations in targeting redox biology for therapeutics
por: Miriam M. Cortese‐Krott, et al.
Publicado: (2025)
por: Miriam M. Cortese‐Krott, et al.
Publicado: (2025)
Preliminary efficacy and safety profile of dual histamine blockade on preventing filgrastim‐associated bone pain in breast cancer patients: Randomized controlled trial
por: Mona M. Eltamalawy, et al.
Publicado: (2025)
por: Mona M. Eltamalawy, et al.
Publicado: (2025)
State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58
por: Richard Kanyo, et al.
Publicado: (2025)
por: Richard Kanyo, et al.
Publicado: (2025)
Autocrine activation of P2X7 receptors mediates catecholamine secretion in chromaffin cells
por: María Constanza Maldifassi, et al.
Publicado: (2024)
por: María Constanza Maldifassi, et al.
Publicado: (2024)
Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39
por: Kira Devantier, et al.
Publicado: (2024)
por: Kira Devantier, et al.
Publicado: (2024)
Ejemplares similares
-
A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors
por: Simon Miguel M. Lopez, et al.
Publicado: (2025) -
Nimodipine reduces microglial activation in vitro as evidenced by morphological phenotype, phagocytic activity and high‐throughput RNA sequencing
por: István Pesti, et al.
Publicado: (2025) -
Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
por: Denise Pajonczyk, et al.
Publicado: (2024) -
Biodiversity2Drugs—Renaissance of exploring nature‐derived peptides for GPCR ligand discovery
por: Christian W. Gruber, et al.
Publicado: (2025) -
Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II‐induced cAMP signalling
por: Sanika Mohagaonkar, et al.
Publicado: (2026)